Merck refiles $11.5B Acceleron deal with the FTC. Is extending the antitrust review period the real reason?

Merck refiles $11.5B Acceleron deal with the FTC. Is extending the antitrust review period the real reason?
aliu
Mon, 11/01/2021 – 09:42